Lupin US market

Lupin scouts for acquisitions in US

Looking to bolster its overseas presence, drug major Lupin is scouting for acquisition opportunities in the US market, especially in inhalers and injectables segments.

Oct 21, 2014, 13:43 PM IST

Lupin expects to launch 20-25 products every year in the US

Drug major Lupin Ltd, the fifth largest generics player in the US, expects to launch 20-25 products in the American market every year in the next couple of years.

May 12, 2013, 11:15 AM IST

Lupin gets USFDA nod for generic Seasonique tablets

Drug major Lupin Friday said it has received US health regulator's approval for generic version of Teva Branded Pharm's Seasonique Tablets, used to prevent pregnancy, in the American market.

Apr 12, 2013, 18:53 PM IST

Lupin gets USFDA nod for generic hypertension drug

The Mumbai-based firm said it has already commenced shipping the product.

Mar 22, 2013, 18:46 PM IST

Lupin receives USFDA nod for Lorazepam Oral Concentrate

Drug firm Lupin Thursday said it has received US health regulator's approval to market its generic Lorazepam Oral Concentrate, used for treating anxiety disorders, in the American market.

Feb 21, 2013, 17:45 PM IST

Lupin to launch 5-6 products in US market in near future

Lupin expects to launch 5-6 products in the near future out of a total of over 100 products, which are awaiting approvals from the US health regulator, a top company official said Thursday.

Jan 31, 2013, 20:32 PM IST

Lupin Q3 Net up 43% at Rs 335 crore

Drug firm Lupin on Thursday posted an increase of 42.57 percent in its consolidated net profit to Rs 335.2 crore for the third quarter ended December 31, 2012, on the back of strong sales in the US market.

Jan 31, 2013, 14:31 PM IST

Lupin looks to acquire brands in the US; eyes 20% growth

Drug major Lupin is looking to acquire brands and technology firms to increase reach in the US market as the company aims to grow sales by over 20 percent in the world's most lucrative drug market over the next two years.

Jul 29, 2012, 12:29 PM IST